Lantheus Holdings (LNTH) Cash & Equivalents (2013 - 2026)
Lantheus Holdings (LNTH) reported Cash & Equivalents of $498.6 million for Q1 2026, down 46.88% year-over-year from $938.5 million in Q1 2025, and up 38.83% quarter-over-quarter from $359.1 million in Q4 2025.
Lantheus Holdings (LNTH) Cash & Equivalents (2013 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 14 years of Cash & Equivalents data on file, last reported at $498.6 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $498.6 million, down 46.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $498.6 million (down 46.88% YoY), and the FY2025 annual result was $359.1 million, down 60.66% from the prior year.
- Cash & Equivalents rose to $498.6 million in Q1 2026 per LNTH's latest filing, from $359.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $938.5 million in Q1 2025 and troughed at $105.4 million in Q1 2022.
- A 5-year average of $546.5 million and a median of $498.6 million in 2026 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents jumped 346.93% in 2023, then sank 60.66% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $415.7 million in 2022, then jumped by 71.7% to $713.7 million in 2023, then increased by 27.91% to $912.8 million in 2024, then slumped by 60.66% to $359.1 million in 2025, then soared by 38.83% to $498.6 million in 2026.
- Business Quant data shows LNTH's Cash & Equivalents at $498.6 million in Q1 2026, $359.1 million in Q4 2025, and $382.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 222.27 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 498.58 Mn |
| Dec 31, 2025 | 359.12 Mn |
| Sep 30, 2025 | 382.01 Mn |
| Jun 30, 2025 | 695.57 Mn |
| Mar 31, 2025 | 938.53 Mn |
| Dec 31, 2024 | 912.81 Mn |
| Sep 30, 2024 | 866.39 Mn |
| Jun 30, 2024 | 757.02 Mn |
| Mar 31, 2024 | 718.28 Mn |
| Dec 31, 2023 | 713.66 Mn |
| Sep 30, 2023 | 614.13 Mn |
| Jun 30, 2023 | 414.08 Mn |
| Mar 31, 2023 | 470.86 Mn |
| Dec 31, 2022 | 415.65 Mn |
| Sep 30, 2022 | 257.26 Mn |
| Jun 30, 2022 | 171.43 Mn |
| Mar 31, 2022 | 105.36 Mn |
| Dec 31, 2021 | 98.51 Mn |
| Sep 30, 2021 | 91.48 Mn |
| Jun 30, 2021 | 91.50 Mn |